Translational research in pancreatic cancer - @crcm_marseille - INSERM U1068
Marseille
Joined November 2022
- Tweets197
- Following4.9K
- Followers1.8K
- Likes569
Pinned Tweet
Today, on #WorldPancreaticCancerDay, we wear 💜 to support those affected by this disease.
Our Pancreatic Cancer Team at @crcm_marseille - @paoli_calmettes is fully committed to advancing research for better diagnosis & treatments, with invaluable support from @laliguecancer.
Le cancer du #pancréas est un défi majeur de #santépublique. Encore difficile à prendre en charge, son traitement manque d'une personnalisation. Les travaux de @NelsonDusetti pourraient tout changer !
Merci de votre soutien. 🧡 lncc.info/pancreas
@paoli_calmettes @Inserm
Nelson Dusetti 🇫🇷 🇦🇷 retweeted
🧬 #Transcriptomic signatures enable #precision chemotherapy in pancreatic cancer
🔸Chemo choice in #PDAC remains empirical
🔸GemPred & GemCore predict gemcitabine benefit
🔸AI-based Pancreas-View guides gemcitabine vs FOLFIRINOX
📖 #OpenAccess 👉 bit.ly/4qDmnLZ
ALT Visual Abstract
Nelson Dusetti 🇫🇷 🇦🇷 retweeted
Securing First Major @FondationARC Funding to Advance PDAC Research - @DornierEmmanuel
@NelsonDusetti
oncodaily.com/voices/emmanue…
#Cancer #Medicine #Health #Oncology #OncoDaily #PDAC #CancerResearch #MedX #MedNews #MedEd
Nelson Dusetti: Advancing Cancer Research Through Collaboration 2025 at the University of Melbourne oncodaily.com/voices/nelson-…
Happy to share our contribution to a new PNAS paper led by CNIO showing that triple inhibition (KRAS^hi + EGFRi + STAT3 PROTAC) achieves complete and durable PDAC regression in PDO/PDX/mouse models. Congrats to all co-authors! pnas.org/doi/10.1073/pnas.25…
Nelson Dusetti 🇫🇷 🇦🇷 retweeted
The Strength and Diversity of Pancreatic Cancer Research in Marseille - @NelsonDusetti
@crcm_marseille @paoli_calmettes @IBDMmarseille
oncodaily.com/voices/nelson-…
#Cancer #Medicine #Health #Oncology #OncoDaily #PancreaticCancer #CancerResearch #Mednews #MedEd
Grateful to the Fundación Ramón Areces for bringing together top experts on PDAC at the Symposium in Madrid, where I had the pleasure to share the session with Peter Bailey, Dieter Saur, Alfredo Carrato, Ignacio Garrido Laguna, Teresa Macarulla
Link: youtu.be/dpsel8xxcVg?si=XBFq…
ALT PROGRAMME SESSION III – Chair: Andrés Muñoz Martín Genetic and non-genetic mechanisms driving progression and resistance to therapy in PDAC – Peter Bailey Tumor–host interactions in pancreatic cancer – Dieter Saur Metabolic crossroads: Exploring the diabetes–obesity–pancreatic cancer axis – Nuria Malats Exploring the molecular routes of resistance in pancreatic cancer – Nelson Dusetti SESSION IV – Chair: Alfredo Carrato Combination strategies to potentiate the effect of KRAS inhibitors – Silvestre Vicent Cambra The long journey to inhibit an “undruggable” target in pancreatic cancer and beyond – Laura Soucek State of the art and new therapeutic options in advanced pancreatic cancer – Teresa Macarulla Targeting KRAS beyond G12C – Ignacio Garrido-Laguna Closing remarks – Alfredo Carrato
Great to join the @CNIOStopCancer & @FundacionAreces meeting on Pancreatic Cancer: Challenges & Future Perspectives.
Key: early detection, new therapies, risk factors, and above all personalization & therapy resistance, our focus at CRCM-IPC.
🔬 Científicos nacionales e internacionales han expuesto sus resultados de investigación sobre #cáncerdepáncreas en un simposio organizado por la #frAreces con los investigadores Mariano Barbacid y Carmen Guerra @CNIOStopCancer
#cancer #salud #medicina #oncologia
New review in Translational Oncology!
PDAC is not static but a phenotypic continuum shaped by epigenetics & the microenvironment.
@crcm_marseille & Medical College of Wisconsin @precision_ru @mellowescenter collaboration.
📄 doi.org/10.1016/j.tranon.202…
#PDAC #Epigenetics
Proud to have contributed to this new work in Science Advances! Congrats to @ShivKSingh6 and team for revealing how TP53 missense mutations fuel plasticity & resistance in PDAC, highlighting the need for combined therapies.🔗 science.org/doi/10.1126/scia…
Honored to see our work highlighted. Our review dives into new avenues for personalized treatment in pancreatic cancer. Hope it’s useful for the community! 👇
📘Future medical management of pancreatic cancer
@myESMO
✅New targets, strategies, personalization
👉cancertreatmentreviews.com/a…
@NelsonDusetti @OncoAlert @realbowtiedoc #cancer #oncology #pancreatic #MedX
Honored to speak at @EurPancClub 🇩🇪 on personalizing pancreatic cancer care & preclinical models.
The data and concepts I presented are detailed in our review 👉 Cancer Treatment Reviews cancertreatmentreviews.com/a…
Thanks @EurPancClub @Anticancerfund @P_C_E_ !
Inspired after the @EurPancClub meeting in Düsseldorf organized by @IEspositoPATH. A wonderful connection has been made with our colleagues @PancreasVerona to collaborate. #PaCaTeam @crcm_marseille, @paoli_calmettes. European Pancreatology at its best 🇫🇷🇮🇹🇪🇺
ALT European Pancreatology at its best where science, pathology, gastroenterology, surgery, and oncology unite for better patient care. Thank you @PancreasVerona for the inspiration and great moment shared. Can’t wait to see what we’ll achieve together! 🇫🇷🇮🇹🇪🇺
Honoured to join experts at the #G7Cancer conference in Paris on June 26, organised by #INCa & NCC Japan.
Proud to represent our work at @crcm_marseille & @paoli_calmettes
Replay here 👉 g7cancer-events.com/live/
Nelson Dusetti 🇫🇷 🇦🇷 retweeted
Yoshi Majima (founder of @PanCAN Japan) has been a passionate advocate for patients & families for over two decades. He talked about his own experience with surveillance and early detection of #PancreaticCancer.
From the G7 Cancer Conference on Poor Prognosis Cancers (Paris).
Nelson Dusetti 🇫🇷 🇦🇷 retweeted
Article on Medical Management of Pancreatic Cancer Just Accepted in Cancer Treatment Reviews - @NelsonDusetti
oncodaily.com/science/nelson…
#Cancer #CancerResearch #CancerTherapy #MedEd #MedX #CancerTreatment #OncoDaily #Oncology #PancreaticDuctalAdenocarcinoma #PDAC
Research Engineer in Molecular Biology and Spatial Transcriptomics (36-month contract – SCHEMA-PDAC project) | EURAXESS euraxess.ec.europa.eu/jobs/3…
Nelson Dusetti 🇫🇷 🇦🇷 retweeted
Excited to announce the kick-off meeting of EU-funded project COMBAT-PDAC - Nelson Dusetti (@NelsonDusetti)
@VHIO @paoli_calmettes
oncodaily.com/blog/nelson-du…
#OncoDaily #Oncology #Cancer #Health #Medicine #MedTwitter #MedEd #MedOnc #MedNews #COMBATPDAC
It has been a privilege to contribute to the work led by Corinne Bousquet’s team on FKBP7 in #PancreaticCancer.
Unveiling FKBP7 as an Early Endoplasmic Reticulum Sentinel in Pancreatic Stellate Cell Activation, Collagen Remodelling and Tumor Progression sciencedirect.com/science/ar…
On March 20, 2025, at Jeudi du PSCC #15, I’ll present our latest research on personalized chemotherapy in pancreatic cancer, focusing on AI-driven heterogeneity deconvolution and preclinical models.
parissaclaycancercluster.org…